NCT00002162已完成2 期
A Randomized, Parallel Arm, Comparative, Open Label, Multicenter Study of the Activity and Safety of Two Formulations of Saquinavir in Combination With Other Antiretroviral Drugs
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 140
- 试验地点
- 27
研究概览
简要总结
To evaluate the antiviral activity and safety of two formulations of saquinavir in combination with licensed nucleoside antiretroviral drugs.
详细描述
Patients are randomized to receive either hard gel or soft gel capsules of saquinavir in combination with at least one licensed nucleoside antiretroviral. Treatment will continue for 48 weeks. After the first 16 weeks, patients will be given the opportunity to roll over to the saquinavir formulation of choice.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
入排标准
- 年龄范围
- 13 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must have:
- •HIV infection.
- •Antiretroviral naiveness (i.e., less than 4 weeks of prior treatment) to at least one of the licensed nucleoside drugs.
- •No more than 2 weeks of prior treatment with a protease inhibitor.
- •No active opportunistic infection or other serious AIDS-defining condition.
排除标准
- •Co-existing Condition:
- •Patients with the following symptoms or conditions are excluded:
- •Malabsorption or inadequate oral intake.
- •Lab or clinical abnormality worse than grade 3 (other than exercise-induced CPK elevations).
- •Unexplained, chronic diarrhea, defined as more than three loose stools per day persisting for 2 weeks or more within the month prior to study entry.
- •Active malignancy or anticipated need for chemotherapy during the study.
- •Anticipated need for disallowed medications during the study.
- •Concurrent Medication:
- •Other protease inhibitors.
- •Prior Medication:
- •More than 4 weeks of the prior nucleoside antiretroviral selected for the patient's regimen.
- •More than 2 weeks of any protease inhibitor.
研究者
研究点 (27)
Loading locations...
相似试验
已完成
2 期
A Phase II Open-Label Exploratory Study of Saquinavir + Zidovudine + Lamivudine in HIV Infected PatientsHIV InfectionsNCT00002190Hoffmann-La Roche30
已完成
1 期
A Comparison of Saquinavir Hard- and Soft-Gelatin Capsules in HIV-Infected PatientsHIV InfectionsNCT00002383Hoffmann-La Roche80
已完成
3 期
A Study of Saquinavir Soft Gelatin Capsules Plus Zidovudine Plus Lamivudine in the Treatment of HIV-1 Infected Patients Who Have Never Taken Anti-HIV DrugsHIV InfectionsNCT00002367Hoffmann-La Roche40
已完成
3 期
A Study of Saquinavir Soft Gelatin Capsules Combined With Other Anti-HIV Drugs in HIV-1 Infected PatientsHIV InfectionsNCT00002374Hoffmann-La Roche120
已完成
3 期
GEMINI Study - A Study of Saquinavir/Ritonavir in Treatment-Naive Patients With HIV-1 InfectionHIV InfectionsNCT00105079Hoffmann-La Roche337